Abarelix (Plenaxis™) and Bevacizumab (Avastin®)

William P. Hogle

doi:10.1188/04.CJON.663-669

We are aware of current issues with the ONS login. Please clear your device history/cache/cookies before attempting to log in. Thank you for your patience as we address this issue.

Abarelix (Plenaxis™) and Bevacizumab (Avastin®)

William P. Hogle

Gena Middleton

Denise V. Lapka

prostatic neoplasms, hormone antagonists, gonadotropins, antibodies, monoclonal, inhibitors, angiogenesis, thromboembolism

CJON 2004, 8(6), 663-669. DOI: 10.1188/04.CJON.663-669

Preview

Members Only

Not a current ONS member or journal subscriber?

Become a Member

Explore the benefits of membership.

Join ONS or Renew Membership

Purchase This Article

Receive a PDF to download and print.